Skip to main content
Advertisement
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
      • Doodle Gallery
      • Circulation Cover Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
      • Hospital Santa Maria del Popolo, Naples, Italy
      • Minneapolis City Hospital
      • Pitié-Salpêtrière Hospital
      • Tufts Medical Center
      • Uppsala University Hospital
      • Vassar Brothers Medical Center (Poughkeepsie, NY)
      • Wroclaw Medical University
    • On My Mind
    • Podcast Archive
      • → Circulation on the Run, FIT Edition
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association

Search for author "A. Michael Lincoff"

  • Modify Search
  • Create Alert
  • Save Search

141 Results

Type a term to search within all articles in this journal: e.g., stem cell
Content Type
Select types of content to include in the results.
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
e.g., 07/28/2017
e.g., 07/28/2017
Format Results
  • Open Access
    Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical PerspectiveThe AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)
    C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington
    Circulation. 2016;134:1918-1930, originally published November 15, 2016
    https://doi.org/10.1161/CIRCULATIONAHA.116.025687
    Download PDF
  • Open Access
    Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical Perspective
    C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. Harrington
    Circulation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687
    View table
    Table 1.
    By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington
    Baseline CharacteristicsShow More
    Baseline CharacteristicsShow Less
  • Open Access
    Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical Perspective
    C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. Harrington
    Circulation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687
    Figure 1.
    Figure 1.
    By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington
    CONSORT (Consolidated Standards of Reporting Trials) diagram. ITT indicates intent to treat...
    Show More
    CONSORT (Consolidated Standards of Reporting Trials) diagram. ITT indicates intent to treat.
    Show Less
  • Open Access
    Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical Perspective
    C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. Harrington
    Circulation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687
    View table
    Table 2.
    By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington
    Coprimary Safety End PointsShow More
    Coprimary Safety End PointsShow Less
  • Open Access
    Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical Perspective
    C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. Harrington
    Circulation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687
    View table
    Table 3.
    By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington
    MACE End Points in the Intent-to-Treat PopulationShow More
    MACE End Points in the Intent-to-Treat PopulationShow Less
  • Open Access
    Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical Perspective
    C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. Harrington
    Circulation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687
    Figure 2.
    Figure 2.
    By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington
    Time to occurrence of first major adverse cardiovascular event (MACE). Composite of cardiov...
    Show More
    Time to occurrence of first major adverse cardiovascular event (MACE). Composite of cardiovascular (CV) death, nonfatal myocardial infarction (MI), ischemic stroke, and hospitalization for unstable angina. HR indicates hazard ratio.
    Show Less
  • Open Access
    Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical Perspective
    C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. Harrington
    Circulation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687
    Figure 3.
    Figure 3.
    By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington
    Time to occurrence of first exploratory major adverse cardiovascular event (MACE). Composit...
    Show More
    Time to occurrence of first exploratory major adverse cardiovascular event (MACE). Composite of cardiovascular (CV) death, nonfatal myocardial infarction (MI), and stroke. HR indicates hazard ratio.
    Show Less
  • Open Access
    Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical Perspective
    C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. Harrington
    Circulation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687
    View table
    Table 4.
    By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington
    Bleeding Academic Research Consortium Evaluation Grades for Worst Bleeding Events: Safety PopulationShow More
    Bleeding Academic Research Consortium Evaluation Grades for Worst Bleeding Events: Safety PopulationShow Less
  • Open Access
    Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical Perspective
    C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. Harrington
    Circulation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687
    View table
    Table 5.
    By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington
    Baseline Lipid and Cardiovascular BiomarkersShow More
    Baseline Lipid and Cardiovascular BiomarkersShow Less
  • Open Access
    Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical Perspective
    C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis, Robert A. Harrington
    Circulation December 2016, 134 (24) 1918-1930; DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025687
    View table
    Table 6.
    By C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, Megan Yee, Purva Jain, John H. Alexander, P. Gabriel Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise M. D’Andrea, Lawrence I. Deckelbaum, Bela Merkely, Maciej Zarebinski, Ton Oude Ophuis and Robert A. Harrington
    Cholesterol Efflux, HDL Cholesterol, and ApoA-I Values Immediately After Infusion of CSL112Show More
    Cholesterol Efflux, HDL Cholesterol, and ApoA-I Values Immediately After Infusion of CSL112Show Less

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 15
  • Next Page
Back to top

Selected Facets

Selected Facets

  • 2013 - 2016 (Publication date)

Journal

Source

  • Circulation: Cardiovascular Interventions 15
  • Circulation: Cardiovascular Quality and Outcomes 20
  • Circulation 106

Article Type

Article Type

  • ACCF/AHA Practice Guideline 58
  • ACS: ECG, Angiography, Imaging-Diagnostic, Pathophysiologic, Prognostic Insights 2
  • Acute Coronary Syndromes 14
  • Acute Coronary Syndromes: Drug Therapies, Bleeding, and Outcomes 1
  • Acute Coronary Syndromes: Insights into Risk and Treatment 2
  • Advances in Antithrombotic Therapies in Acute Coronary Syndromes 1
  • Antithrombin Therapy for ACS 2
  • Atherosclerosis, Vascular Biology and Development 1
  • Catheter-Based Coronary Interventions: Stent Complications 2
  • Catheter-Based Coronary Interventions: Stents: Registry Reports 1
  • Catheter-Based Coronary Interventions: Stents: Safety Issues 1
  • Catheter-based coronary interventions: stents 7
  • Clinical Science 20
  • Contemporary STE and NSTE ACS Care 1
  • Core 2. Epidemiology and Prevention of CV Disease: Physiology, Pharmacology and Lifestyle 1
  • Core 2: Epidemiology and Prevention of CV Disease: Physiology, Pharmacology, and Lifestyle 2
  • Core 6. Catheter-based and Surgical Interventions 1
  • Core 7. Vascular Disease: Biology and Clinical Science 3
  • Coronary Interventions 15
  • Coronary Stent Thrombosis 2
  • Featured Research: Thrombin Inhibition, Bleeding, and Outcomes in ACS 4
  • Intervention and Surgery 1
  • Lifestyle Factors 1
  • New Drugs and Technologies 8
  • Original Article 16
  • Original Articles 15
  • Original Articles Original Article Original Articles 8
  • Original Articles Original Article Original Articles Coronary Interventions 7
  • Original Research Article 10
  • Percutaneous Coronary Intervention 6
  • Poster 4
  • Poster Session Title: Poster Session III 2
  • Prognosis and Pharmacologic Therapy in ACS 1
  • Risk Factor Interventions: Effects and Impact 2
  • Secondary prevention 8
  • Session Title: ACS and PCI: 30-Day Outcomes and Posthospitalization Care 1
  • Session Title: CTOs, Left Mains, Bifurcations and Multivessel Disease 1
  • Session Title: Diabetes Mellitus and CVD: Mechanistic Insights 1
  • Session Title: HDL and the Artery Wall 1
  • Session Title: Myocardial Protection, Intraoperative Management, and Postoperative Critical Care 1
  • Session Title: Poster Session III 4
  • Session Title: Unstable Angina, NSTEMI and STEMI: Prognosis and Pharmacologic Therapy-Focus on Patient Risk 1
  • Session Title: Unstable Angina, NSTEMI and STEMI: Prognosis and Pharmacological Therapy 1
  • Session Title: What's New in the Treatment of Patients with Acute Coronary Syndromes? 1
  • Type 2 diabetes 7
  • Volume 126, Issue 21 Supplement; November 20, 2012 / Abstracts From the American Heart Association 2012 Scientific Sessions and Resuscitation Science Symposium 1
  • Show More
  • Show Less

Subject

Subject

  • CPR and emergency cardiac care 58
  • Catheter-based coronary interventions: stents 15
  • Lipids and Cholesterol 10
  • Secondary prevention 16
  • Type 2 diabetes 23
  • Volume 126, Issue 21 Supplement; November 20, 2012 / Abstracts From the American Heart Association 2012 Scientific Sessions and Resuscitation Science Symposium 1

Content Type

Resource Type

  • Articles 32
  • Tables & Figures 60
  • HWTABLE 49
Advertisement
Advertisement

Circulation

  • About Circulation
  • Instructions for Authors
  • Circulation CME
  • Statements and Guidelines
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451
email: circ@circulationjournal.org
 

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2017 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured